Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
With the supply of Paxlovid being a problem as noted in the article, and should Apabetalone proves to be successful in the next couple of months, this may give us the cover we need to announce a competitive Canadian therapeutic that is anti-viral, and anti-inflammatory. The timing couldn't be any better.
